Company Overview of SimeTRA Pharm Ltd.
SimeTRA Pharm, Ltd. develops drugs and therapies-based on ARTS, a pro-apoptotic protein, for cancer treatment in Israel. Its product focuses on treating Hematopoietic cancers. The company was founded in 2004 and is based in Kiryat Shmona, Israel.
P. O. Box 408
South Industrial zone
Kiryat Shmona, 11013
Founded in 2004
972 4 681 8801
972 4 681 8806
Key Executives for SimeTRA Pharm Ltd.
Similar Private Companies By Industry
|Abital Pharma Pipelines Ltd.||Middle East/Africa|
|Active PX Ltd.||Middle East/Africa|
|Advanced Inhalation Technology Ltd.||Middle East/Africa|
|Alvit LCS Pharma Ltd||Middle East/Africa|
|Angio B Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact SimeTRA Pharm Ltd., please visit www.simetrapharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.